Pediatric Emergency Unit, Rio Hortega University Hospital, Valladolid, Spain
Pediatric Emergency Department, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces. University of the Basque Country, UPV/EHU, Bilbao, Basque Country, Spain.
Arch Dis Child. 2021 Jul 19;106(8):758-763. doi: 10.1136/archdischild-2020-320468.
To develop and validate a prediction rule to identify well-appearing febrile infants aged ≤90 days with an abnormal urine dipstick at low risk of invasive bacterial infections (IBIs, bacteraemia or bacterial meningitis).
Ambispective, multicentre study.
The derivation set in a single paediatric emergency department (ED) between 2003 and 2017. The validation set in 21 European EDs between December 2017 and November 2019.
Two sets of well-appearing febrile infants aged ≤90 days with an abnormal urine dipstick (either leucocyte esterase and/or nitrite positive test).
Prevalence of IBI in low-risk infants according to the RISeuP score.
We included 662 infants in the derivation set (IBI rate:5.2%). After logistic regression, we developed a score (RISeuP score) including age (≤15 days old), serum procalcitonin (≥0.6 ng/mL) and C reactive protein (≥20 mg/L) as risk factors. The absence of any risk factor had a sensitivity of 96.0% (95% CI 80.5% to 99.3%), a negative predictive value of 99.4% (95% CI 96.4% to 99.9%) and a specificity of 32.9% (95% CI 28.8% to 37.3%) for ruling out an IBI. Applying it in the 449 infants of the validation set (IBI rate 4.9%), sensitivity, negative predictive value and specificity were 100% (95% CI 87.1% to 100%), 100% (95% CI 97.3% to 100%) and 29.7% (95% CI 25.8% to 33.8%), respectively.
This prediction rule accurately identified well-appearing febrile infants aged ≤90 days with an abnormal urine dipstick at low risk of IBI. This score can be used to guide initial clinical decision-making in these patients, selecting infants suitable for an outpatient management.
制定并验证一个预测规则,以识别表现良好的≤90 天龄、尿液干化学检查异常的发热婴儿,其患有侵袭性细菌感染(IBI,菌血症或细菌性脑膜炎)的风险较低。
前瞻性、多中心研究。
2003 年至 2017 年期间,在单家儿科急诊室(ED)进行的推导集;2017 年 12 月至 2019 年 11 月期间,在 21 家欧洲 ED 进行的验证集。
两组表现良好的≤90 天龄、尿液干化学检查异常(白细胞酯酶和/或亚硝酸盐阳性)的发热婴儿。
RISeuP 评分中低危婴儿的 IBI 发生率。
我们纳入了推导集中的 662 名婴儿(IBI 发生率:5.2%)。经过逻辑回归,我们制定了一个评分(RISeuP 评分),包括年龄(≤15 天)、血清降钙素原(≥0.6ng/mL)和 C 反应蛋白(≥20mg/L)作为危险因素。无任何危险因素的敏感性为 96.0%(95%CI80.5%99.3%),阴性预测值为 99.4%(95%CI96.4%99.9%),特异性为 32.9%(95%CI28.8%37.3%),可排除 IBI。在 449 名验证集中的婴儿中应用该评分(IBI 发生率为 4.9%),其敏感性、阴性预测值和特异性分别为 100%(95%CI87.1%100%)、100%(95%CI97.3%100%)和 29.7%(95%CI25.8%33.8%)。
该预测规则准确地识别了表现良好的≤90 天龄、尿液干化学检查异常的发热婴儿,其患有 IBI 的风险较低。该评分可用于指导这些患者的初始临床决策,选择适合门诊管理的婴儿。